2367.HK

Giant Biogene has Entered Offering Stage: China's Leading Skin Treatment Company with Annual Profits of More Than RMB800 Million

Retrieved on: 
星期三, 十月 26, 2022

Among them, Giant Biogene is a leader in the bioactive ingredient-based professional skin treatment product industry in China and is the second-largest professional skin treatment product company in China in terms of retail sales in 2021.

Key Points: 
  • Among them, Giant Biogene is a leader in the bioactive ingredient-based professional skin treatment product industry in China and is the second-largest professional skin treatment product company in China in terms of retail sales in 2021.
  • The Company has officially entered the offering stage in the Hong Kong stock market, adding another high-quality investment target in the biotechnology field, and being the first listed company in collagen.
  • In the field of skincare, collagen has been expanding its market share due to its favourable skin regeneration and anti-aging properties.
  • Giant Biogene has been the largest collagen-based professional skin treatment product company by retail sales in China for the latest three consecutive years since 2019.